Biden Says Medicare, Medicaid Should Cover Obesity Drugs—What Could That Mean for Access?
The Biden Administration proposed a rule on Tuesday that would require Medicare and Medicaid to cover weight loss drugs as treatments for obesity. If enacted, the policy would go into effect in 2026. Currently, these programs cover popular glucagon-like peptide-1 (GLP-1) drugs such as Ozempic, but only for indications other than weight loss, such as […]